Clinical ResearchResearch compound

Bacopa monnieri

Ayurvedic herb, bacoside glycosides, memory + anxiolytic.

Telegram

WHAT IS BACOPA MONNIERI?

Detailed overview

Bacopa monnieri (Brahmi) is the classical "medhya rasayana" (intellect-tonifying) herb of Ayurvedic medicine. Its actives are bacoside A and B (and derivatives), triterpene saponins. Multiple double-blind placebo-controlled human trials (RCT, 12 weeks, 300-600 mg standardized 50% bacoside extract) describe **memory consolidation and reaction-time improvement**, though the effect size is modest (Calabrese 2008 BMC RCT, Stough 2001). **A standardized extract (45-55% bacosides)** is mandatory for efficacy – under-standardized product is inert. Acute effect is minimal, **8-12 weeks of chronic dosing** are needed to reach plateau. Common side effect: gastrointestinal discomfort if taken on an empty stomach → take with food. Anecdotally a short-term "echoing" or "slowness" sensation is also reported – a kind of serotonergic-slowing effect.

Mechanism

Antioxidant + cholinergic + BDNF

Onset

4-12 weeks chronic use

Legal status

OTC dietary supplement

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • Gastrointestinal discomfort: nausea, abdominal cramping, increased bowel motility and loose stools, especially on an empty stomach
  • Dry mouth and increased thirst (cholinergic effect)
  • Fatigue, sedation or a feeling of mental slowness, linked to serotonergic dampening
  • Reduced appetite or mild stomach upset
  • Headache or dizziness with chronic use (rare, individual sensitivity)

Contraindications · 5

  • Pregnancy and breastfeeding: insufficient safety data, avoid
  • Thyroid disorders: bacosides may raise T4 levels, caution in hyperthyroidism and with thyroid medication
  • Bradycardia and cholinergic drugs: additive heart-rate slowing, caution with beta blockers and calcium channel blockers
  • Peptic ulcer or bowel obstruction: increased secretion and motility may worsen it
  • Interaction with sedatives and anticholinergic agents: increased sedation or counteracted effect

Related Nootropics

Same therapeutic category

Telegram

Have a question about Bacopa monnieri?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Telegram
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 19, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.